DemeRx, Inc., a clinical-stage biopharmaceutical company dedicated to transforming addiction therapeutics, today announced the appointment of Michael Snitkovsky as chief operations officer, adding a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results